pamidronate has been researched along with HIV Wasting Syndrome in 1 studies
HIV Wasting Syndrome: Involuntary weight loss of greater than 10 percent associated with intermittent or constant fever and chronic diarrhea or fatigue for more than 30 days in the absence of a defined cause other than HIV infection. A constant feature is major muscle wasting with scattered myofiber degeneration. A variety of etiologies, which vary among patients, contributes to this syndrome. (From Harrison's Principles of Internal Medicine, 13th ed, p1611).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a male patient with advanced AIDS who developed hypercalcemia 2 weeks after institution of rhGH therapy." | 1.30 | Hypercalcemia in an AIDS patient treated with growth hormone. ( Hartzband, P; Lally, M; Sakoulas, G; Tritos, NA; Wanke, C, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakoulas, G | 1 |
| Tritos, NA | 1 |
| Lally, M | 1 |
| Wanke, C | 1 |
| Hartzband, P | 1 |
1 other study available for pamidronate and HIV Wasting Syndrome
| Article | Year |
|---|---|
Hypercalcemia in an AIDS patient treated with growth hormone.
Topics: Acquired Immunodeficiency Syndrome; Adult; Calcium; Diphosphonates; Growth Hormone; HIV Wasting Synd | 1997 |